We are live on ! Find out more
HURA

TuHURA Biosciences
HURA

24 hedge funds and large institutions have $4.65M invested in TuHURA Biosciences in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 7

0% more funds holding

Funds holding: 24 → 24 (0)

0% more ownership

Funds ownership: 0% → 0.01% (+0%)

20% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 5

26% less capital invested

Capital invested by funds: $6.31M → $4.65M (-$1.67M)

Holders
24
Holders Change
–
Holders Change %
0%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
4
Reduced
5
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$3.05M
2
BFM
Boothbay Fund Management
New York
+$704K
3
NCM
Nantahala Capital Management
Connecticut
+$210K
4
Two Sigma Investments
Two Sigma Investments
New York
+$81.4K
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$23.6K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$104K
2
PVI
Pura Vida Investments
New York
-$64K
3
VF
Virtu Financial
New York
-$60.4K
4
Envestnet Asset Management
Envestnet Asset Management
Illinois
-$44K
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$23K
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$1.75M +$3.05M +1,163 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$969K +$5.25K +2 +0.3%
NCM
3
Nantahala Capital Management
Connecticut
$582K +$210K +80 +27%
BFM
4
Boothbay Fund Management
New York
$403K +$704K +268 New
Geode Capital Management
5
Geode Capital Management
Massachusetts
$251K +$21K +8 +5%
S
6
swisspartners
Liechtenstein
$237K – – –
State Street
7
State Street
Massachusetts
$100K +$10.5K +4 +6%
BlackRock
8
BlackRock
New York
$64K -$2.63K -1 -2%
GSEP
9
Golden State Equity Partners
California
$55K -$10.5K -4 -10%
Two Sigma Investments
10
Two Sigma Investments
New York
$47K +$81.4K +31 New
Northern Trust
11
Northern Trust
Illinois
$38K – – –
RE
12
RBC Europe
United Kingdom
$32.4K – – –
RFA
13
Reilly Financial Advisors
California
$22K – – –
ECM
14
Evergreen Capital Management
Washington
$21K – – –
FNB
15
Farmers National Bank
Kentucky
$14K +$15.8K +6 New
RJA
16
Raymond James & Associates
Florida
$14K – – –
Fidelity Investments
17
Fidelity Investments
Massachusetts
$13K +$23.6K +9 New
VF
18
Virtu Financial
New York
$12K -$60.4K -23 -74%
MWM
19
Maltin Wealth Management
New Jersey
$9K +$15.8K +6 New
Morgan Stanley
20
Morgan Stanley
New York
$5K – – –
UBS Group
21
UBS Group
Switzerland
$3K -$2.63K -1 -33%
LC
22
Lindbrook Capital
California
$2K -$5.25K -2 -67%
Koshinski Asset Management
23
Koshinski Asset Management
Illinois
$1.72K +$2.63K +1 New
Osaic Holdings
24
Osaic Holdings
Arizona
$1K -$10.5K -4 Closed
WQ
25
Wealth Quarterback
New Jersey
$1K – – –
1
2

HURA Hedge Fund Activity: Q3 2021 in Review

24 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q3 2021, worth a combined $4.65M — down 26% from $6.31M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new HURA positions and 7 closed out — a net gain of 1 holder — while 4 added to existing stakes and 5 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $3.05M. The largest seller was Citadel Advisors, exiting entirely with an estimated $104K sold.

  • 24 institutional investors held TuHURA Biosciences (HURA) as of Q3 2021, unchanged from Q2 2021.
  • Funds reported $4.65M of TuHURA Biosciences stock for Q3 2021, down 26% quarter-over-quarter.
  • 8 funds opened new TuHURA Biosciences positions in Q3 2021 and 7 closed out, a net change of +1 holder.
  • The largest TuHURA Biosciences buyer in Q3 2021 was Armistice Capital, an estimated $3.05M added.
  • The largest TuHURA Biosciences seller in Q3 2021 was Citadel Advisors, an estimated $104K sold.

Based on aggregated 13F filings for Q3 2021.